NMPA Approval

Guselkumab Injection (Intravenous Infusion)

Approval Number

国药准字SJ20250006

Registration Date

February 20, 2025

Drug Information

Generic Name

古塞奇尤单抗注射液(静脉输注)

Trade Name

特诺雅达

Dosage Form

注射剂

Strength

200mg/20mL/瓶

Drug Type

生物制品

Registration Date

February 20, 2025

Expiry Date

February 19, 2030

Company Address

Turnhoutseweg 30, B-2340 Beerse,Belgium

Company NameCilag AG

Company Address

Hochstrasse 201, 8200 Schaffhausen, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

古塞奇尤单抗注射液(静脉输注) - NMPA 批准文号 | MedPath